| Hangzhou Luckysage Sciene and Technology Co., Ltd. | China | Inquire | ||
|---|---|---|---|---|
![]() | www.luckysagechem.com | |||
![]() | +86 (571) 8819-9336 +86 13355710209 | |||
![]() | +86 (571) 8819-0523 | |||
![]() | sales@luckysagechem.com | |||
![]() | QQ Chat | |||
| Chemical manufacturer | ||||
| chemBlink Standard supplier since 2010 | ||||
| BOC Sciences | USA | Inquire | ||
|---|---|---|---|---|
![]() | www.bocsci.com | |||
![]() | +1 (631) 485-4226 | |||
![]() | +1 (631) 614-7828 | |||
![]() | info@bocsci.com | |||
| Chemical manufacturer | ||||
| chemBlink Standard supplier since 2010 | ||||
| Zhuhai Hairuide Bioscience and Technology Co., Ltd. | China | Inquire | ||
|---|---|---|---|---|
![]() | www.zhhairuide.com | |||
![]() | +86 (756) 778-9199 +86 13326687259 +86 13326687289 +86 15913232160 | |||
![]() | +86 (756) 778-9099 | |||
![]() | sales@zhhairuide.com zhengyanhong@zhhairuide.com | |||
![]() | QQ Chat | |||
![]() | Skype Chat | |||
| Chemical manufacturer since 2009 | ||||
| chemBlink Standard supplier since 2019 | ||||
| Santa Cruz Biotechnology, Inc. | USA | Inquire | ||
|---|---|---|---|---|
![]() | www.scbt.com | |||
![]() | +1 (831) 457-3800 | |||
![]() | +1 (831) 457-3801 | |||
![]() | scbt@scbt.com | |||
| Chemical manufacturer | ||||
| Actylis | USA | Inquire | ||
|---|---|---|---|---|
![]() | actylis.com | |||
![]() | +1 (516) 627-6000 | |||
![]() | +1 (516) 627-6093 | |||
![]() | info@actylis.com | |||
| Chemical manufacturer | ||||
| Classification | API >> Antiallergic >> Antihistamine |
|---|---|
| Name | Triprolidine hydrochloride |
| Synonyms | 2-(1-(4-Methylphenyl)-3-(1-pyrrolidinyl)-1-propenyl)pyridine monohydrochloride; (E)-2-[3-(1-Pyrrolidinyl)-1-p-tolylpropenyl]pyridine hydrochloride |
| Molecular Structure | ![]() |
| Molecular Formula | C19H22N2.HCl |
| Molecular Weight | 314.85 |
| CAS Registry Number | 6138-79-0 |
| EC Number | 627-740-2 |
| Melting point | 115-120 °C |
|---|---|
| Water solubility | >=10 g/100 mL at 20 °C |
| Hazard Symbols | |||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Risk Statements | R22;R36/37/38 Details | ||||||||||||||||||||||||||||||||||||
| Safety Statements | S26;S36 Details | ||||||||||||||||||||||||||||||||||||
| Hazard Classification | |||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||
| SDS | Available | ||||||||||||||||||||||||||||||||||||
| Market Analysis Reports |
| List of Reports Available for Triprolidine hydrochloride |